🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I trial studies the side effects and how well surgery and heated...
Status
Active Not Recruiting
Location
City of Hope Corona
Start Date
2014-05-19
Trial ID
NCT01970722
A multicenter, low-intervention, drug-based study to evaluate the feasibili...
Status
Recruiting
Location
HCUVA
Start Date
2023-02-27
Trial ID
NCT06902467
The purpose of this study is to test whether it is safe to treat your cance...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2006-08
Trial ID
NCT00588237
Treatments Being Tested
The purpose of this study is to evaluate giving chemotherapy drugs directly...
Status
Terminated
Location
University of Oklahoma Health Sciences Center
Start Date
2006-01
Trial ID
NCT00582205
Treatments Being Tested
CHIMOVIP is a study to determine the best therapeutic strategy in patient w...
Status
Recruiting
Location
Centre Georges François Leclerc
Start Date
2016-10
Trial ID
NCT03025477
This phase II trial tests how well concentrating heated (hyperthermic) chem...
Status
Enrolling By Invitation
Location
Mayo Clinic in Rochester
Start Date
2025-12-03
Trial ID
NCT07139951
This phase I trial studies the side effects of pressurized intraperitoneal ...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2020-08-21
Trial ID
NCT04329494
This randomized phase III trial studies bevacizumab and intravenous (given ...
Status
Completed
Location
University of Alabama at Birmingham Cancer Center
Start Date
2009-08-11
Trial ID
NCT00951496
The purpose of this study is to test the safety of the drug olaparib at dif...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center at Basking Ridge
Start Date
2014-04-21
Trial ID
NCT02121990
Treatments Being Tested
RATIONAL FOR STUDYING IV NAC AS POTENTIAL CHEMOPROTECTANT: Cisplatin has s...
Status
Withdrawn
Location
Oregon Health & Science University
Start Date
2010-06
Trial ID
NCT01138137
Treatments Being Tested